STOCK TITAN

IOVANCE (IOVA) COO reports RSU vesting and tax-withheld shares on Form 4

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

IOVANCE BIOTHERAPEUTICS Chief Operating Officer Igor Bilinsky reported routine equity compensation activity. On the transaction date, 8,790 restricted stock units (RSUs) vested into an equal number of common shares. The company withheld 4,473 shares at $3.96 per share to cover mandatory tax obligations, which was not an open-market sale. Following these transactions, Bilinsky directly held 134,556 shares of common stock and 26,369 RSUs that will continue to vest in equal quarterly installments.

Positive

  • None.

Negative

  • None.
Insider BILINSKY IGOR
Role Chief Operating Officer
Type Security Shares Price Value
Exercise Restricted Stock Units 8,790 $0.00 --
Exercise Common Stock 8,790 $0.00 --
Tax Withholding Common Stock 4,473 $3.96 $18K
Holdings After Transaction: Restricted Stock Units — 26,369 shares (Direct, null); Common Stock — 134,556 shares (Direct, null)
Footnotes (1)
  1. Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. Represents common stock remaining after deducting the common stock withheld for taxes. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The remaining RSUs will vest in equal quarterly installments. Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.
RSUs vested 8,790 units Restricted stock units converting into common stock on transaction date
Shares withheld for taxes 4,473 shares at $3.96 Mandatory tax withholding on RSU vesting
Common shares held after transactions 134,556 shares Direct IOVANCE common stock holdings post-transaction
Remaining RSUs 26,369 units RSUs outstanding after this vesting, vesting in equal quarterly installments
RSU exercise price $0.00 per unit Conversion of RSUs into common stock at no exercise cost
Restricted Stock Units financial
"security_title: "Restricted Stock Units" and footnote describing RSUs vesting"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding requirements financial
"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting"
derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
contingent right financial
"Each RSU represents a contingent right to receive one share of the Issuer's common stock."
open market sale financial
"This is not an open market sale of securities."
An open market sale is when a company or a shareholder sells shares through the regular stock market to any willing buyer, using ordinary exchange trading rather than private deals. It matters to investors because it increases the number of shares available and can push the price down or change ownership balance—think of it like someone putting extra items on a supermarket shelf for any shopper to buy, which can lower the item's price if supply suddenly grows.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BILINSKY IGOR

(Last)(First)(Middle)
C/O IOVANCE BIOTHERAPEUTICS, INC.
825 INDUSTRIAL ROAD, SUITE 100

(Street)
SAN CARLOS CALIFORNIA 94070

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
IOVANCE BIOTHERAPEUTICS, INC. [ IOVA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Operating Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock(1)06/01/2026M8,790A$0134,556D
Common Stock(2)06/01/2026F4,473D$3.96130,083(3)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(4)06/01/2026M8,790 (5) (5)Common stock8,790$0.0026,369(6)D
Explanation of Responses:
1. Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.
2. Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
3. Represents common stock remaining after deducting the common stock withheld for taxes.
4. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
5. The remaining RSUs will vest in equal quarterly installments.
6. Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.
/s/ Igor Bilinsky06/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did IOVA COO Igor Bilinsky report on this Form 4?

Igor Bilinsky reported vesting of 8,790 restricted stock units into common shares and a related tax-withholding disposition of 4,473 shares at $3.96 each. These moves reflect routine equity compensation events rather than open-market buying or selling activity.

Were Igor Bilinsky’s IOVA share dispositions open-market sales?

No, the 4,473 IOVANCE shares were withheld by the company to satisfy mandatory tax obligations on RSU vesting. A footnote clarifies this was not an open-market sale, but a standard tax-withholding mechanism commonly used for equity compensation.

How many IOVA shares does Igor Bilinsky hold after these transactions?

After the reported transactions, Igor Bilinsky directly holds 134,556 shares of IOVANCE common stock. This figure reflects his position following the RSU vesting and the tax-withheld shares, providing context for the scale of this routine compensation-related event.

What happened to Igor Bilinsky’s restricted stock units (RSUs) in this IOVA filing?

In this filing, 8,790 RSUs vested, each converting into one share of IOVANCE common stock. After vesting, 26,369 RSUs remain outstanding. A footnote notes these remaining RSUs will vest in equal quarterly installments going forward.

Does the IOVA Form 4 show any open-market buying or selling by the COO?

The Form 4 does not show any open-market purchases or sales. It records an RSU vesting, an associated derivative exercise, and shares withheld for taxes. All activity is compensation-related rather than discretionary trading in the open market.

How many IOVA shares were used to cover Igor Bilinsky’s tax obligations?

A total of 4,473 IOVANCE common shares were withheld to satisfy mandatory tax withholding requirements when the RSUs vested. The filing specifies this withholding as a tax payment mechanism and clarifies it should not be interpreted as an open-market sale.